Innovation
3 patent families — focus: Chemistry & metallurgy; filing pace slowing. Cited 6 times.
| Year | Filings |
|---|---|
| 2022 | 2 |
| 2023 | 1 |
Investor mix
7 investors on record; lead investors include Sofinnova Partners, AbbVie, T1D Fund, Roche.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 57% |
| Private equity | 1 | 14% |
| Other / undisclosed | 2 | 29% |